Immature phenotypes of iPSC-cardiomyocytes represent a major limitation to the productivity of human cell-based assays for cardiotoxicity. In this webinar, Drs. Block and Herron will describe CELLvo™ Matrix Plus. A human cell-derived extracellular matrix substrate that rapidly matures cardiomyocytes in monolayer culture for predictive cardiotoxicity assays. Further, they will introduce CELLvo™ iPSC-derived atrial cardiomyocytes. By utilizing chamber specific cardiomyocytes, StemBioSys has introduced a new layer of nuance and biological-relevance to in vitro testing.

Presenters: Drs. Travis Block and Todd Herron

Listen to the recording now.

If you attended the event and have questions, feel free to email us here.